Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines. | Syngene International Syngene International is integrated research, development, and manufacturing company providing scientific services. | Biological E Biological E (also known as BE, formerly Biological Products Private) is a biological products and pharmaceuticals company that manufacturer and supplies vaccines. | Novo Nordisk Novo Nordisk is a healthcare company that designs and manufactures pharmaceutical products. | UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 1995 | Founding Date 1993 | Founding Date 1953 | Founding Date 1923 | Founding Date 1928 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations New Delhi, IN HQ | Locations Bangalore, IN HQ Bangalore, IN Bengaluru, IN | Locations Hyderabad, IN HQ Hyderabad, IN Kolthur, IN Zug, CH Cary, US | Locations Bagsværd, DK HQ Tirana, AL Boufarik, DZ Hydra, DZ Tizi Ouzou, DZ Buenos Aires, AR North Sydney, AU see more | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 14,8411% increase | Employees 6,510 | Employees 3,9201% increase | Employees 64,31917% increase | Employees 9,000 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 599.3 b | Valuation ($) 34.3 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ₹33.7b (FY, 2024) | Revenue (est.) ₹9.3b (FY, 2019) | Revenue (est.) kr232.3b (FY, 2023) | Revenue (est.) €4.9b (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods ₹9.3b (FY, 2024) | Cost of goods N/A | Cost of goods kr30.8b (FY, 2023) | Cost of goods €1b (FY, 2023) |
Gross profit | Gross profit N/A | Gross profit ₹25.6b (FY, 2024) | Gross profit N/A | Gross profit kr202b (FY, 2023) | Gross profit €4.8b (FY, 2023) |
Net income | Net income N/A | Net income ₹5.1b (FY, 2024) | Net income N/A | Net income kr83.7b (FY, 2023) | Net income €343m (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised $ 239m | Total funding raised $ 62m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |